Home workouts tested as therapy for rare lung disease
NCT ID NCT06804122
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a 12-week home exercise program can improve exercise capacity and quality of life in 20 adults with pulmonary arterial hypertension (PAH). Participants receive guidance from a physiotherapist to do endurance and strength training at home. The main goal is to see if walking distance increases by at least 33 meters.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
exercise training (endurance and strength training at home with physiotherapist guidance)
What this could lead to
If successful, this could provide a safe, home-based exercise program that improves walking ability and quality of life for people with pulmonary arterial hypertension.
What could go wrong
This is a small, early-phase study with only 20 participants, so results may not apply to all patients. Exercise may not provide significant benefits, and adherence at home could be low.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tampere Heart Hospital
RECRUITINGTampere, Pirkanmaa, 33300, Finland
Contact Phone: •••-•••-•••• Email: •••••@•••••